A comprehensive review of WHO cancer medicine recommendations for African countries reveals three critical findings that demand attention from healthcare policymakers and implementers. First, only 11% of WHO modifications between 2017 and 2023 included economic data—meaning 89% lacked cost information essential for resource allocation decisions. Second, all available cost-effectiveness studies demonstrated poor transferability to African contexts, making global evidence minimally useful for local policy decisions. Third, despite limited economic guidance, African countries adopted approximately 23% of new recommendations for adult national lists and 13% for pediatric lists.
These findings underscore that current global guidance mechanisms fail to address the economic realities facing resource-limited health systems. Healthcare leaders implementing WHO recommendations should advocate for context-specific economic evidence and conduct local affordability assessments before adoption decisions.
Was this article helpful?
